Lifeward (LFWD) EBIT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -33.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.20% |
| Dec 31, 2025 | -0.75% |
| Sep 30, 2025 | 16.70% |
| Jun 30, 2025 | -14.47% |
| Mar 31, 2025 | -4.21% |
| Dec 31, 2024 | -58.41% |
| Sep 30, 2024 | -6.04% |
| Jun 30, 2024 | -12.25% |
| Mar 31, 2024 | -29.11% |
| Dec 31, 2023 | -30.19% |
| Sep 30, 2023 | -37.29% |
| Jun 30, 2023 | -26.43% |
| Mar 31, 2023 | -6.70% |
| Dec 31, 2022 | -15.99% |
| Sep 30, 2022 | -21.47% |
| Jun 30, 2022 | -1.10% |
| Mar 31, 2022 | -6.25% |
| Dec 31, 2021 | -33.39% |
| Sep 30, 2021 | 13.57% |
| Jun 30, 2021 | 15.88% |
| Mar 31, 2021 | 19.73% |
| Dec 31, 2020 | 20.89% |
| Sep 30, 2020 | 16.92% |
| Jun 30, 2020 | 21.95% |
| Mar 31, 2020 | 13.96% |
| Dec 31, 2019 | 26.37% |
| Sep 30, 2019 | 25.74% |
| Jun 30, 2019 | 21.00% |
| Mar 31, 2019 | 17.71% |
| Dec 31, 2018 | 49.87% |
| Sep 30, 2018 | 13.20% |
| Jun 30, 2018 | 3.35% |
| Mar 31, 2018 | -1.90% |
| Dec 31, 2017 | -2.10% |
| Sep 30, 2017 | 11.77% |
| Dec 31, 2016 | -43.48% |
| Sep 30, 2016 | -48.91% |